9926:HKG
Akeso Inc
HK$91.30
arrow_upward
+0.94%(+0.85) 1H
16 Okt, 4:08:14 PTG GMT+8 · HKD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 9926...
Buka
HK$92.15
Tinggi
HK$95.30
Rendah
HK$90.15
Permodalan Pasaran
84.10B
Purata volum
10.45J
Volum
11.09J
tgi 52 mgu
HK$156.00
rdh 52 mgu
HK$80.20
EPS
-HK$1.24
Bilangan pekerja
4K
Buka
HK$92.15
Tinggi
HK$95.30
Rendah
HK$90.15
Permodalan Pasaran
84.10B
Purata volum
10.45J
Volum
11.09J
tgi 52 mgu
HK$156.00
rdh 52 mgu
HK$80.20
EPS
-HK$1.24
Bilangan pekerja
4K
Cerita berita
Daripada sumber web dan rakan kongsi berita
www.tokenpost.com
·
10 jam lalu
Dan Kirsche Sees Strong U.S. Stock Gains in November and December
Simply Wall Street
·
20 minit lalu
Microsoft (MSFT) Secures 1,100 MW Indiana Power Deal
Yahoo Finance
·
34 minit lalu
3 Reasons the Vanguard S&P 500 ETF Could Be Worth Holding for the Next 20 Years
ad-hoc-news.de
·
1 jam lalu
Insulet stock stood at USD 141.10 on October 16, 2026, 60.24 percent below 52-week high
Profil
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
Perihal Akeso Inc
CEOMichelle Xia | Michelle Xia
Pekerja4.08K
Diasaskan19 Mac 2012
Ibu pejabat-
Sektor-
Laman webakesobio.com